Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report)’s stock price was down 4.8% on Friday . The stock traded as low as $14.52 and last traded at $14.70. Approximately 23,268 shares changed hands during trading, a decline of 96% from the average daily volume of 561,417 shares. The stock had previously closed at $15.44. Analyst […]
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Shares Gap Up to $12 82 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
NEW YORK and SAN DIEGO, Dec. 01, 2023 Zentalis® Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule.
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
In the realm of stock market movements, insider trading activity is often a significant indicator that investors monitor to gauge the confidence of management and key stakeholders in the company's future.